MedTrace Logo

Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation

NCT03080896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-05-28

No results posted yet for this study

Summary

Using a combination of the video-laryngoscope with the disposable fiber-optic bronchoscope (aScope III) is a feasible way to facilitate successful intubation in a timely manner, in patients with predicted difficult airway due to tumors in the oral cavity, pharynx or larynx To test the hypothesis that combination of video-laryngoscope with the fiber-optic bronchoscope is superior to video-laryngoscope alone for intubation of patients with oral cavity, pharyngeal or laryngeal pathologies undergoing surgery

Conditions

  • Intubation; Difficult

Interventions

DEVICE

King Vision video-laryngoscope with #3 disposable blade and endotracheal tube stylet

intubation using King Vision video-laryngoscope with #3 disposable blade with stylet convert to intubation with video-laryngoscope and fiber-optic bronchoscope bronchoscope (aScope III) for failure to intubate after three attempts

DEVICE

fiberoptic bronchoscope aScope III

Intubation using the videolaryngoscope/fiberoptic bronchoscope (aScope III)

Sponsors & Collaborators

  • Ambu A/S

    collaborator INDUSTRY

  • University of Louisville

    lead OTHER

Principal Investigators

  • Rainer Lenhardt, MD MBA · University of Louisville 530 South Jackson Street Louisville, KY 40202

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2024-03-31
Completion
2024-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03080896 on ClinicalTrials.gov